[The transcutaneous treatment of superficial thrombophlebitis with the exogenous nitric oxide donor: nitroglycerin]

Rev Esp Cardiol. 1991 Jun-Jul;44(6):424-6.
[Article in Spanish]

Abstract

Nitroglycerin (glyceryl trinitrate) is a substance that is metabolized to nitric oxide in the cell. Its action is not dependent of the endothelium derived nitric oxide, but imitates those of this biological mediator. We thought that nitroglycerin should have the same in vivo actions as the endogenous nitric oxide in vitro has. We report and discuss the first patient with superficial thrombophlebitis successfully treated with transdermal nitroglycerin.

Publication types

  • Case Reports
  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Administration, Cutaneous
  • Aged
  • Arm / blood supply
  • Heart Failure / complications
  • Heart Failure / therapy
  • Humans
  • Iatrogenic Disease
  • Male
  • Nitroglycerin / administration & dosage*
  • Thrombophlebitis / drug therapy*
  • Thrombophlebitis / etiology

Substances

  • Nitroglycerin